PRX-115

BIOLOGICAL2 trials

Sponsors

Protalix

Conditions

Gout

Phase 1

A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels

CompletedNCT05745727

Start: 2023-03-23End: 2025-02-06Updated: 2025-02-11

Phase 2

A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)

RecruitingNCT07280156

Start: 2025-12-22End: 2028-06-01Target: 150Updated: 2026-06-11